Literature DB >> 7102422

Prevention of symptomatic vasospasm by topically applied nimodipine.

L M Auer, Z Ito, A Suzuki, H Ohta.   

Abstract

A 2.4 x 10(-5) M solution of the Calcium-antagonist Nimodipine was administered to the exposed cerebral vessels in 17 patients intraoperatively clipping of a ruptured aneurysm. The interval between subarachnoid haemorrhage and operation was 48 to 72 hours. The CT investigation had revealed blood accumulation in the basal cisterns in all cases. Vasodilatation was observed in all instances; the percentage being greater in small vessels as compared to large vessels. Postoperatively, a neurological deficit combined with angiographically verified vasospasm occurred in two patients, but was reversible in both. Fifteen patients remained free from symptomatic vasospasm and were discharged without neurological deficit. In 13 of these patients and 3 additional cases, a plastic cannula was placed intraoperatively so that postoperative topical administration of Nimodipine was possible. Postoperative control-angiograms after a mean interval of 7 days from SAH did not show severe spasm in any of the patients; localised moderate asymptomatic spasm was found in 8 cases and was reserved in 5. Moderate postoperative symptomatic spasm was observed in 2 patients, treated and reversed in one patient. In 5 of 7 cases without evidence of spasm in the angiogram postoperative topical administration of Nimodipine caused vasodilatation. It is concluded, that topical intracisternal administration of Nimodipine reverses intraoperative vascular spasm and decreases the probability of postoperative symptomatic vasospasm after early surgery.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7102422     DOI: 10.1007/BF01728885

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

1.  Early operation for the ruptured intracranial aneurysm.

Authors:  J Suzuki; T Yoshimoto
Journal:  Jpn J Surg       Date:  1973-09

2.  Intracranial arterial spasm: a clinical analysis.

Authors:  R H Wilkins; J A Alexander; G L Odom
Journal:  J Neurosurg       Date:  1968-08       Impact factor: 5.115

3.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

4.  [Cerebral infraction due to vasospasm, revealed by computed tomography (author's transl)].

Authors:  H Ohta; Z Ito
Journal:  Neurol Med Chir (Tokyo)       Date:  1981-04       Impact factor: 1.742

5.  Extensive evacuation of subarachnoid clot for prevention of vasospasm--effective or not?

Authors:  H Ohta; Z Ito; N Yasui; A Suzuki
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

6.  Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage. IV. Cerebral angiography. An analysis of the diagnostic value and complications of carotid and vertebral angiography in 5,484 patients.

Authors:  G Perret; H Nishioka
Journal:  J Neurosurg       Date:  1966-07       Impact factor: 5.115

7.  Pial arterial vasodilation by intravenous nimodipine in cats.

Authors:  L M Auer
Journal:  Arzneimittelforschung       Date:  1981

8.  The pathophysiology of cerebral vasospasm, and pharmacological approaches to its management.

Authors:  R Towart
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

  8 in total
  20 in total

1.  Intraoperative use of laser Doppler in the study of cerebral microvascular circulation.

Authors:  V A Fasano; R Urciuoli; P Bolognese; M Mostert
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

2.  Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model.

Authors:  M Murat Firat; Veli Gelebek; Hakan S Orer; Deniz Belen; Ahmet K Firat; Ferhun Balkanci
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

3.  The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs.

Authors:  M Shibuya; Y Suzuki; M Takayasu; T Asano; T Harada; I Ikegaki; S Satoh; H Hidaka
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

4.  Intracranial effects of nicardipine.

Authors:  M R Gaab; T Czech; A Korn
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Investigation of nimodipine pharmacokinetics in Chinese patients with acute subarachnoid haemorrhage.

Authors:  C R Kumana; M Kou; Y L Yu; K Y Fong; C F Fung; C M Chang; W Mück; I J Lauder
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage.

Authors:  M Shibuya; Y Suzuki; H Enomoto; T Okada; K Ogura; K Sugita
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine.

Authors:  J Philippon; R Grob; F Dagreou; M Guggiari; M Rivierez; P Viars
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

8.  [Effect of the Ca antagonist nimodipine on global and regional cerebrovascular circulation].

Authors:  M R Gaab; C P Rode; E H Schakel; I Haubitz; J Bockhorn; A Brawanski
Journal:  Klin Wochenschr       Date:  1985-01-02

9.  Topical application of dexamethasone to prevent cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a pilot study.

Authors:  Luo Fei; Filimon Golwa
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

10.  Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo.

Authors:  Serge Marbacher; Volker Neuschmelting; Thilo Graupner; Stephan M Jakob; Javier Fandino
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.